Executive Director of Clinical Development (Rare Disease)
Recursion(1 day ago)
About this role
Executive Director of Clinical Development at Recursion leading clinical programs for novel small‑molecule therapeutics in cancer and rare diseases. The role translates Recursion’s platform‑driven science into clinical development strategies from IND to proof‑of‑concept and supports regulatory and business development activities. It reports to the VP of Clinical Development and contributes to cross‑functional execution to advance medicines to patients.
Required Skills
- Drug Development
- Clinical Trials
- Regulatory Submissions
- Clinical Pharmacology
- Precision Medicine
- Rare Diseases
- Program Leadership
- Clinical Strategy
- Medical Expertise
- External Collaboration
Qualifications
- Medical Degree
- MD/PhD Preferred
About Recursion
recursion.comRecursion is a TechBio company that combines high-throughput experimental biology, automated imaging, and machine learning to decode biology and accelerate drug discovery. Its platform integrates large-scale biological datasets, AI models, and laboratory automation to identify and advance therapeutic candidates across multiple modalities and disease areas. Recursion develops an internal pipeline of programs and partners with biopharma and investors to translate discoveries into clinical-stage medicines. The company emphasizes a platform-first, scalable approach to make drug discovery faster, more reproducible, and more data-driven.
Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at Recursion
Similar Jobs
Clinical Trial Manager
Entrada Therapeutics(13 days ago)
Sr. Director/Safety Scientist, Pharmacovigilance Operations
BridgeBio Pharma(7 days ago)
Head of Clinical Development
Betting Hero(1 month ago)
Head of Clinical Development
Flagship Pioneering, Inc.(1 month ago)
Senior Scientist / Principal Scientist, Chemistry Lead
Relay Therapeutics(1 month ago)
Senior Medical Director, Skeletal Dysplasia, International
BridgeBio Pharma(4 days ago)